Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Titel:
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Auteur:
Hoffman, Veena Hallas, Jesper Linder, Marie Margulis, Andrea V. Suehs, Brandon T. Arana, Alejandro Phiri, Kelesitse Enger, Cheryl Horter, Libby Odsbu, Ingvild Olesen, Morten Perez-Gutthann, Susana Xu, Yihua Kristiansen, Nina Sahlertz Appenteng, Kwame de Vogel, Stefan Seeger, John D. ,